The condition of either the presence of infrequent or shallow breathing or small pauses in breathing is referred to as sleep apnea. The different categories of sleep apnea include central sleep apnea, obstructive sleep apnea, and mixed sleep apnea. The rise in the relative number of sleep apnea cases is mostly attributed to conditions such as obesity, Type II diabetes, cognitive heart failure, hypertension, coronary artery disease, stroke, and atrial fibrillation. Majority of studies have demonstrated results that over 70% of cases of Type II diabetes patients suffer from sleep apnea and about 70% of hypertensive patient also suffer from sleep apnea. This has propelled the growth for sleep apnea devices market.
Factors attributing to the growth of global sleep apnea devices market include increasing co-morbid condition incidence that include type II diabetes, cardiovascular diseases, hypertension, and obesity. Also, technological advancements related to patient comfort and safety, and government initiatives targeted at cutting down the healthcare expenses associated with these diseases will lead to the further development of this market.
The global sleep apnea device market has been categorized based on diagnostic devices into pulse oximeters, actigraphy devices, PSG, and others. The diagnostic device market segment of sleep apnea devices commanded a major share owing to various technical advancements pertaining to the devices and rising awareness among people through NGO and government initiatives.
Based on therapeutic devices, the market is categorized into CPAP devices, BiPAP devices, and others. Based on type of oxygen devices, the sleep apnea device market has been segmented into portable oxygen concentrators, oxygen concentrators, liquid portable oxygen, oral appliances, and ASV devices. On the basis of end users, the global sleep apnea devices market is segmented into sleep laboratories, home care and hospitals. Currently, the home care segment is expected to command the highest share and grow at a rapid pace owing to the patient preference for home-care devices. Also, the increasing trend of using home sleep testing devices as compared to visiting sleep laboratories is estimated to boost the growth of home care market segment.
Geographically, the market is divided into various regions such as North America, Europe, Asia- Pacific, Latin America and Middle East and Africa (MEA). North America commanded the major share in the global sleep apnea devices market owing to the proliferative developments in healthcare infrastructure present in the U.S. In the European nations, owing to the rising awareness towards sleep apnea, along with the improved reimbursement scenario in many countries, the sleep apnea devices market is expected to witness a fast paced growth. Also, various interventions by government and trade associations to treat untreated sleep apnea, will serve to boost the market growth in this region. However, it is expected that sleep apnea device market in Asia-Pacific region will grow at a rapid pace during the future years owing to the rising awareness and increased economic feasibility of the patients.
The key players operating in the sleep apnea device market are ResMed, Fisher & Paykel Healthcare Ltd., SomnoMed, GE Healthcare, Compumedics Ltd., Philips Healthcare, Whole You, Inc., Cadwell Industries Inc. and Carefusion among others.
Market by Type
· Diagnostic devices
o Polysomnography (PSG) Devices
o Respiratory Polygraphs
o Single- Channel Screening Devices (Pulse Oximeters)
o Actigraphy Systems
· Therapeutic devices
o Positive Airway Pressure (PAP) Devices
o Facial Interface
o Adaptive Servo- Ventilation (ASV)
o Airway Clearance Systems
o Oxygen Concentrators
o Oral Appliance
o Other Accessories
Market by End-user
· Home Care Settings
· Sleep Laboratories and Hospitals
Market by Geography
· North America
o Rest of Europe
o Rest of Asia-Pacific
· Latin America
o Rest of Latin America
· Middle East and Africa (MEA)
o South Africa
o Saudi Arabia
o Rest of MEA
Introduction: Meningococcal vaccines are utilized to treat meningitis brought about by bacterium N. meningitidis. Beforehand there were no careful steps accessible to maintain a strategic distance from meningitis. Anti-infection agents alongside supplement supplements were utilized to treat this ailment after the disease was affirmed. In any case, with the approach of the meningoco
Introduction According to Acumen Research and Consulting, the global Sports Medicine market is expected to grow at noteworthy CAGR around 7% throughout the forecast period and reach around US$ 13 billion by 2026. Sports Medicine is a genetic disorder that causes structural abnormalities in hemoglobin molecules. Hemoglobinopathie
Introduction According to Acumen Research and Consulting, the global Real-time PCR (qPCR) & Digital PCR (dPCR) market is expected to grow at noteworthy CAGR around 8.1 % throughout the forecast period and reach around US$ 4.2 billion by 2026. In order to amplify or make more copies of the deoxyribonucleic acid (DNA) sequence
Introduction According to Acumen Research and Consulting, the global Nebulizer market is expected to grow at noteworthy CAGR around 6.2 % throughout the forecast period and reach around US$ 1.4 billion by 2026. Nebulizer is a medical device that converts the medicine into a nebula and directly into the pulmonary system. Nebuliza
Introduction According to Acumen Research and Consulting, the global Motion Preservation Devices market is expected to grow at noteworthy CAGR around 10.5 % throughout the forecast period and reach around US$ 1.5 billion by 2026. In spinal disorders, movement preservation devices are used. Motion conservation devices are used to
Introduction According to Acumen Research and Consulting, the global Hemoglobinopathy market is expected to grow at noteworthy CAGR around 10 % throughout the forecast period and reach around US$ 12 billion by 2026. Hemoglobinopathy is a genetic disorder that causes structural abnormalities in hemoglobin molecules. Hemoglobinopa